title: Removal of Dabigatran Is Superior by Sustained Low Efficient Dialysis (SLED) Compared to Intermittent Hemodialysis.
authors.affiliation: Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University Hospital Tuebingen, Tuebingen, Germany.
authors.forename: Ferruh
authors.initials: F
authors.lastname: Artunc
authors.forename: Thomas
authors.initials: T
authors.lastname: Muehlbacher
authors.forename: Dorothea
authors.initials: D
authors.lastname: Baumann
authors.forename: Ingvild
authors.initials: I
authors.lastname: Birschmann
authors.forename: Joachim
authors.initials: J
authors.lastname: Kuhn
authors.forename: Nils
authors.initials: N
authors.lastname: Heyne
authors.forename: Andreas
authors.initials: A
authors.lastname: Peter
mesh_terms: D058186:Acute Kidney Injury / Q000097:blood / Q000209:etiology / Q000628:therapy; D000369:Aged, 80 and over; D000991:Antithrombins / Q000097:blood / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D000069604:Dabigatran / Q000097:blood / Q000378:metabolism*; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D006435:Renal Dialysis / Q000379:methods*; D053719:Tandem Mass Spectrometry
chemical_list: D000991:Antithrombins; D000069604:Dabigatran